William Aliski

Insider Reports History

Location
Novato, CA
Signature
/s/ Adam S. Mostafa, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Aliski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Director Common Stock 66,849 $1,403,829 $21.00 24 Jun 2021 Direct
Ultragenyx Pharmaceutical Inc. Director Common Stock 10,456 $219,576 $21.00 24 Jun 2021 By trust
X4 Pharmaceuticals, Inc Director Common Stock 96,667 $85,241 $0.8818 10 Jun 2024 Direct
Ultragenyx Pharmaceutical Inc. Director Stock Option (Right to Buy) 4,125 24 Jun 2021 Direct
APPLIED GENETIC TECHNOLOGIES CORP Director Common Stock 0 $0.7745 30 Nov 2022 Direct
APPLIED GENETIC TECHNOLOGIES CORP Director Stock Option (Right to Buy) 0 30 Nov 2022 Direct

Insider Reports Filed by William Aliski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XFOR X4 Pharmaceuticals, Inc 10 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:13
XFOR X4 Pharmaceuticals, Inc 13 Jun 2023 1 $0 4 Director 14 Jun 2023, 17:10
/report/000106299322023027-aliski-william-2022-11-30 APPLIED GENETIC TECHNOLOGIES CORP 30 Nov 2022 6 $0 4 Director 01 Dec 2022, 08:21
XFOR X4 Pharmaceuticals, Inc 06 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:15
/report/000106299321012049-aliski-william-2021-11-30 APPLIED GENETIC TECHNOLOGIES CORP 30 Nov 2021 1 $0 4 Director 02 Dec 2021, 17:43
RARE Ultragenyx Pharmaceutical Inc. 24 Jun 2021 2 $0 4 Director 28 Jun 2021, 18:26
XFOR X4 Pharmaceuticals, Inc 02 Jun 2021 1 +$57,000 4 Director 02 Jun 2021, 17:03